DNA and Gene Chip - Global Strategic Business Report

Global DNA and Gene Chip Market to Reach $20.5 Billion by 2030

The global market for DNA and Gene Chip estimated at US$8.4 Billion in the year 2022, is projected to reach a revised size of US$20.5 Billion by 2030, growing at a CAGR of 11.8% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 11.6% CAGR and reach US$12.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instrumentation segment is readjusted to a revised 12.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 16.4% CAGR

The DNA and Gene Chip market in the U.S. is estimated at US$2.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Select Competitors (Total 32 Featured) -

• Affymetrix Inc
• Agilent Technologies Inc.
• Applied Microarrays Inc.
• Arrayit Corp.
• Biomérieux SA
• Biometrix Technology Inc.
• Bioneer Corp.
• Canon Inc.
• Capitalbio Corp.
• Cytopathfinder Inc.
• Eurofins Mwg Operon
• Exiqon
• Genisphere LLC
• Greiner Bio-One
• Hitachi Ltd.
• Illumina Inc.
• Integrated Dna Technologies
• LC Sciences
• Life Technologies Corp.
• Lifegen Technologies
• Macrogen Inc.
• Microarrays Inc.
• NGK Insulators Ltd.
• Ocimum Biosolutions Ltd.
• Oxford Gene Technology
• Pamgene International B.V.
• Perkinelmer
• Promega Corp.
• Roche Nimblegen Inc.
• Samsung Electronics Co Ltd.
• Savyon Diagnostics Ltd.
• Scienion AG
• Sequenom Inc.
• Shanghai Biochip Co Ltd.
• Sigma-Aldrich
• Surmodics Inc.
• Thermo Fisher Scientific Inc.
• Toshiba Corp.
• Wafergen Biosystems Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year